DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC FIBR012 MCLF015CN 6H A19 ziprasidone 4uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF015CN

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR012 MCLF015CN 6H A19 ziprasidone 4uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:312 KB

Size In Bytes:131 KB

Sha256:06bb2251a56682244436a5396f146d9faa50974bf7f2fc88c4ec1b329010bdf5

Persistent Id:drs://drs.lincs-dcic.org/8e5bcf6e4fd71afe09d76e0833c6ed54

Mime Type:application/gzip

Md5:8e5bcf6e4fd71afe09d76e0833c6ed54

Filename:L1000_LINCS_DCIC_FIBR012_MCLF015CN_6H_A19_ziprasidone_4uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/8e5bcf6e4fd71afe09d76e0833c6ed54

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR012 MCLF015CN 6H A19 ziprasidone 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR012 MCLF015CN 6H A19 ziprasidone 4uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.